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ного церулоплазмина и экспрессии мРНК TNFα в тка-
нях печени этих животных.  
Таким образом, полученные данные свидетельст-
вуют о протективном эффекте метформина на угле-
водный, липидный обмен, а также уровень экспрес-
сии провоспалительных факторов, связанных с NFkB-
сигнальным путем в тканях печени мышей, которые 
находились на диете с высоким содержанием фрук-
тозы. 
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ENGLISH VERSION: INFLUENCE OF METFORMIN ON LIPID 
METABOLISM AND CHRONIC INFLAMMATION IN THE LIVER 
TISSUES OF MICE ON A DIET RICH IN FRUCTOSE* 
Shlykova O.A. , Mikityuk M.V. , Bobrova N.L.. , Izmailova O.V. , Mamontova T.V. , Baranova A.F. , Vesnina L.E. , Kaidashev I.P.  
Higher State Educational Establishment of Ukraine “Ukrainian Medical Stomatological Academy”, Poltava 
The effect of metformin on lipid metabolism and the expression of pro-inflammatory factors in the liver tissue of mice 
that were on a diet rich in fructose (DRF) (60 g fructose / 100 g of food) has been studied. The concentrations of total 
cholesterol (TC), triglycerides (TG), ceruloplasmin (CP), glucose in serum and mRNA expression of inhibitor of NF-kB 
(IkBα), mRNA of tumor necrosis factor α (TNFα) have been determined in homogenates of liver tissues in 3-months-
aged mice of BALBc line weighing 25-30 g. It has been demonstrated that increasing the content of fructose in the diet 
leads to increased concentrations of glucose, TC and TG in the blood of mice. Manifestations of systemic inflammatory 
response become stronger, as evidenced by the increase in CP in the blood serum and the expression level of mRNA of 
TNFα in liver tissues of animals that were on a DRF. Metformin in the dose of 50 mg / kg per day reduced the production 
of triglycerides in the blood serum of mice that were on a DRF; it contributed to the normalization of hepatic gluconeo-
genesis. Administering metformin caused anti-inflammatory effect by lowering serum CP and expression of mRNA of 
TNFα in liver tissues of these animals. Thus, the data suggest the protective effect of metformin on lipid metabolism and 
the expression of pro-inflammatory factors associated with NF-kB-signaling pathway in the liver tissues of mice which 
were on a DRF.  
Keywords: diet rich in fructose, metformin, expression, proinflammatory factors. 
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Numerous studies display that diet rich in fructose 
(DRF) causes various pathological changes, including 
oxidative stress, impaired glucose tolerance, insulin re-
sistance, type 2 diabetes, liver conditions, hypertension 
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and other cardiovascular diseases [16]. It is shown that 
lipid metabolism in the development of stress of hepato-
cytes in animals on DRF occurs in the result of fructose 
metabolism overload [11]. It is assumed that the in-
creased production of lipids in the liver enhances mito-
chondrial beta-oxidation of fatty acids, generation of per-
oxidation products that stimulate IkB-kinase (IKK), and 
therefore the activation of NFkB [7]. It is known that mo-
lecular mechanisms of chronic low-level systemic in-
flammation (CSI) are closely associated with the activa-
tion of proinflammatory nuclear transcription factors 
(NTF), primarily NFkB [5]. 
In recent years, the concept of permanent NF-kB ac-
tivation (long-term and low-intensity) has been formulated 
as a possible model of pathological process that deter-
mines the relationship between insulin resistance, 
chronic inflammation, hypertension, endothelial dysfunc-
tion and dyslipidemia (І.P. Kaidashev, 2012). In this re-
gard, the search for methods to reduce the transcriptional 
activity of NF-kB (diet, exercise, therapeutic drugs) is 
relevant, since it will eliminate the molecular basis of the 
metabolic / insulin resistance syndrome and reduce the 
risk of cardiovascular diseases [2]. Previous studies have 
shown that activation of metformin reduces NFkB, possi-
bly by inhibiting the activation of IKK [1]. 
The aim of the research is to study the influence of 
metformin on blood glucose, lipid metabolism and the 
level of expression of proinflammatory factors in the liver 
tissues of mice that were on a diet rich in fructose. 
Materials and methods of the research 
The experiment was performed on mice of BALBc line 
aged 3 months, weighing 25-30 g, kept in polypropylene 
cages under controlled conditions of 12 hours light / 12 
hours dark cycle. Animals were on a standard diet (60% 
of vegetable amylum) and with unlimited access to water 
for one week. The study was conducted in accordance 
with authorization of the Bioethics Commission of Higher 
State Educational Establishment of Ukraine “Ukrainian 
Medical Stomatological Academy”. 
In a week after acclimation period, the animals were 
divided into four equal groups: group 1 – mice on a stan-
dard diet and water; group 2 – mice on a standard diet 
and water, which were administered metformin (per os) in 
a dose of 50 mg / kg from the 85th day of the experiment 
for 49 days [14, 15]; group 3 – mice on a DRF (60 g fruc-
tose / 100 g of food); group 4 – mice on a DRF, which 
were administered metformin (per os) in a dose of 50 mg 
/ kg from the 85th day of the experiment for 49 days. 
The standard diet comprised the grain mixture 
(wheat, oats, barley, and millet), maize, sunflower seeds, 
peas, corn granules, nuts, and dried fruit. Mineral com-
ponent were: calcium, phosphorus, potassium, sodium. 
Vitamins: A, B1, B2, D3, E, N. The nutrient content: crude 
protein – 11%; crude fat – 4.0%; crude fiber – 10.0%; 
calcium – 0.15%, phosphorus – 0 1%; moisture – 10%. 
On the 134th day of the experiment, after 12-hour 
fasting period, the concentration of glucose in blood se-
rum of animals was determined before and in 120 min-
utes after the glucose load (2 g / kg) (test the glucose tol-
erance). The concentration of glucose (GL) was deter-
mined in blood from the tail vein using “GLYUKOFOT” 
glucometer with standard indicator strips “GEMOGLAN” 
(PIE “NORM”, Ukraine). 
On the 135th day of the experimental period, the ani-
mals were euthanized by cervical dislocation. Blood was 
collected in dry plastic vials. Serum was separated by 
centrifugation at 400 g for 10 minutes. In blood serum, 
concentration of total cholesterol (TC) and triglycerides 
(TG) using the reagents kit (LACHEMA, Czech Republic), 
the concentration of ceruloplasmin (CP) by enzymatic 
oxidation of p-phenyldiamine were determined [3]. The 
sampling of liver tissue was performed and homogenised 
on ice in refrigerated 0.1M phosphate buffer, pH 7.4. In 
liver homogenate, the content of RNA messenger 
(mRNA), NF-kB inhibitor (IkBα) and mRNA of tumor ne-
crosis factor α (TNFα), isolated using the reagents kit 
“Ribo-sol-B” (AmpliSens, Russia), were determined. For 
obtaining cDNA in the reverse transcription reaction, 
primer oligo (dT) 18 and reverse transcriptase M-MuLV 
(SibEnzyme, Russia) were used. Gene expression was 
analyzed by PCR method in “real time”, using oligonu-
cleotide primers for cDNA IkBα:  
5'-TGAAGGACGAGGAGTACGAGC-3';  
5'-TTCGTGGATGATTGCCAAGTG-3' and TNFα:  
5'-CCCTCACACTCAGATCATCTTCT-3';  
5'-GCTACGACGTGGGCTACAG-3', in the presence of 
the dye SYBR Green I (“Synthol”, Russia), using the de-
tecting amplifier DT-322 (“DNA Technology”, Russia) via 
relative quantitative analysis. The gene of glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) was used 
as a reference gene: 5'-AACTTTGGCATTGTGGAAGG-
3'; 5'-GGATGCAGGGATGATGTTCT-3'. 
For data analysis, relative Ct method with the calcula-
tion formula ∆Ct was used [18]. 
The results were processed statistically using the 
program STATISTICA 6.0. (“StatSoft”, USA). The data 
are presented as the sample average (M), the sample 
standard deviation (S / D). The critical level of signifi-
cance when testing the statistical hypotheses was set at 
0.05. 
Results and discussion 
As our research has shown, the gradual increase in 
body weight of mice in the studied groups during the trial 
period was observed. Table 1 displays that the final av-
erage body weight of mice (g) in group 1 was 32,9 ± 2,0; 
in groups 2, 3 and 4: 34,7 ± 2,33; 29,9 ± 5,29; 31,1 ± 
2,08, respectively. It should be noted that the average 
value of the final weight of mice in groups did not differ 
significantly from each other. 
Table 1.  
Change in body weight in the studied groups of animals (M ± 
SD). 
Groups Parameter 
1 2 3 4 
Initial 
body 
weight, g 
28,4±2,2 31,2±1,56 25,9±2,1 29,2±1,13 
Body 
weight in 
84 days, g 
32,6±2,8 33,7±0,77 28,8±3,2 30,3±1,36 
Body 
weight in 
134 days, 
g 
32,9±2,0 34,7±2,33 29,9±5,29 31,1±2,08 
 
When determining the glucose tolerance, a statisti-
cally significant increase in concentration of GL (in fasting 
state) in the blood of mice on DRF was observed, unlike 
the mice of group 1 (p = 0.0059) (Fig.1). Under the influ-
ence of metformin, glucose concentration in the blood 
serum of mice from group 4 was reduced in comparison 
with group 3 (p = 0.052) (Figure 1) 
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Figure 1. Glucose level in groups of studied animals in fasting 
state and in 120 min after the glucose load (2 g / kg).  
Note: * − p <0.05 as compared with group 1. 
In our studies, the lipogenesis processes in liver cells 
varied under the influence of DRF, as evidenced by the 
increase in TC to 3.05 ± 0.57 mmol / l and triglyceride to 
2.15 + 0.42 mmol / l in the serum of group 3 as compared 
with mice of group 1, who were on a standard diet with 
no added fructose (p <0.05) (Table 2). 
Table 2.  
Changes in the level of total cholesterol and triglycerides in the 
serum of studied animals (M + SD). 
Groups Parameter 
1 2 3 4 
TC, mmol / l 1,6 ± 0,38 
1,75 ± 
0,31 
3,05 ± 
0,57* 
2,6 ± 
0,46 
TG, mmol / l  1,13 ±0,57 
1,3 ± 
0,35 
2,15 ± 
0,42* 
1,48 ± 
0,23** 
Note: * − p <0.05 as compared with group 1; 
** − p <0.05 as compared with group 3. 
Metformin reduced the intensity of lipogenesis in liver 
cells of group 4, as evidenced by reduction in triglyc-
erides (1,48 ± 0,23 mmol / l) as compared to group 3 
(2,15 ± 0,23 mmol / l) (p = 0.049), the TC level did not 
significantly change (p = 0.2) (Table 2). 
At the same time, according to histological studies, no 
clinically significant structural changes in liver tissues 
were observed in the studied groups of mice. The indica-
tors of liver mass coefficient in the studied groups of ani-
mal did not change as well, amounting in group 1 – 0,056 
± 0,008, group 2 – 0,054 ± 0,003, group 3 – 0,06 ± 0,009, 
group 4 – 0,061 ± 0,01. 
At the next stage of work, manifestations of systemic 
inflammatory response were assessed. As markers of the 
inflammatory process, the level of CP in blood serum and 
the expression of mRNA of TNFα and IκBα in liver ho-
mogenates were determined. In previous studies of I. P. 
Kaidashev et al., 2008, it was assumed that the contents 
of CP in serum may be a marker of increased risk of in-
flammation and metabolic syndrome, and along with 
other indicators, it will allow assessing the level of sys-
temic inflammatory response [4]. As seen from the data 
presented in Figure 2, the increase in fructose content in 
the diet led to a significant increase in the level of ceru-
loplasmin in serum of group 3 – 297.65 + 17.07 mg / l as 
compared with group 1 – 221.9 + 18,5 mg / l (p = 
0.0004). 
 
Figure 2. Changes in the level of ceruloplasmin in groups of 
studied animals.  
Note: * − p <0.05 as compared with group 1;  
** − p <0.05 as compared with group 3. 
The expression of mRNA of TNFα and IkBα in liver 
tissues of mice by increasing the content of fructose in 
the diet, as well as under exposure to metformin, was 
studied. 
In the group of animals on a DRF, expression of 
mRNA of TNFα increased and expression of mRNA of 
IkBα did not virtually change (Table 3). 
Under the action of metformin, the manifestations of 
chronic inflammation reduced due to decrease of ceru-
loplasmin level in serum of animals from group 4 (246,67 
± 15,41 mg / l) as compared to group 3 (297,65 ± 17,07 
mg / L) (p = 0.0044) (Figure 2). Under the influence of 
metformin, expression of mRNA of TNFα in liver cells de-
creased. Metformin had virtually no effect on expression 
of mRNA of IκBα (Table 3). 
Table 3.  
Changes in the relative mRNA expression of mRNA of TNFα 
and IkBα in liver tissues of studied animals (M ± SD). 
Groups Parameter 
1 2 3 4 
Expression 
of TNF-
alpha, ∆Ct 
14,67 
±0,74  
11,62 
±0,78 
12,42 
±0,94* 
14,75 
±1,04** 
Expression 
of IkB-alpha, 
∆Ct 
11,2 
±1,04 
10,0 
±0,28 
10,62 
±0,88 
11,2 
±1,97 
Note: * − p <0.05 as compared with group 1; 
** − p <0.05 as compared with group 3. 
In our study it has been demonstrated that the in-
crease of fructose content in the diet leads to increased 
concentrations of glucose, TC and TG in the blood of 
mice. Manifestations of systemic inflammatory response 
are exacerbated, as evidenced by the increase in the 
level of ceruloplasmin in serum and the level of expres-
sion of mRNA of TNFα in liver tissues of animals that 
were on DRF. At the same time, we observed no in-
crease in body mass and structural changes in the liver 
tissue of mice by high fructose intake with food. 
The data on the changes in the process of lipogene-
sis in liver cells of mice on a DRF are consistent with 
studies of H. Basciano et al, 2005, in which it is shown 
that large admission of fructose to the liver activates the 
metabolism of glucose and the way of its assimilation, 
leads to a significant increase in the rate of de novo lipo-
genesis, the synthesis of triglycerides (TG), which is due 
to the high flux of glycerol and acyl molecule units of fruc-
tose catabolism. These metabolic disorders appear to be 
one of the reasons underlying the induction of insulin re-
sistance, which is often observed in humans and animals 
with large consumption of dietary fructose [8]. 
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No increase in body weight of mice, as well as the 
lack of changes in weight and structure of the liver in our 
studies may be due to the high content of dietary fiber in 
the diet of mice. Numerous experimental and clinical 
studies have shown beneficial effects of a diet high in 
dietary fiber for metabolic syndrome [6, 9, 10]. 
Strengthening the systemic inflammatory response in 
our study is confirmed by an increased concentration of 
serum ceruloplasmin and expression of mRNA of TNFα 
in the liver, and as is known, TNFα is a marker of activa-
tion of NFkB. There is evidence to show that hepatic in-
sulin resistance induced by NFkB activation is associated 
with increased expression of TNFα, IL-6 and IL-1 [12]. 
In our previous studies it has been suggested that 
metformin affects NFkB-signaling pathway, possibly by 
changing the activity of IKK [1]. IKK activation is one of 
the key mediators of insulin resistance, as evidenced by 
the increased sensitivity to insulin at directed disorders in 
IKK gene [17]. Considering the fact that in this study the 
activation of NFkB in the liver of mice may be associated 
with overexpression of IKK, causing resistance of liver 
and skeletal muscle to the action of insulin and signs of 
systemic inflammatory response (increase of serum IL-6) 
[13], we continued to study the effect of metformin on 
NFkB-signaling pathway in the experiment. 
In our study, metformin at 50 mg / kg reduced the 
production of triglycerides in liver cells of mice that were 
on DRF, facilitated normalization of hepatic gluconeo-
genesis. Administering metformin has anti-inflammatory 
effect, by reducing the concentration of serum ceru-
loplasmin and expression of mRNA of TNFα in liver tis-
sues of these animals. 
Thus, the findings suggest that metformin has protec-
tive effect on carbohydrate and lipid metabolism, as well 
as the level of expression of proinflammatory factors as-
sociated with NFkB-signaling pathway in liver tissues of 
mice that were on a diet rich in fructose. 
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